StockNews.com Begins Coverage on Calithera Biosciences (NASDAQ:CALA)

Equities researchers at StockNews.com started coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a report issued on Thursday. The firm set a “hold” rating on the biotechnology company’s stock.

Calithera Biosciences Price Performance

Shares of NASDAQ CALA opened at $0.01 on Thursday. The firm has a fifty day moving average price of $0.01 and a 200-day moving average price of $0.02. Calithera Biosciences has a 1 year low of $0.00 and a 1 year high of $0.12.

About Calithera Biosciences

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.